Evidence map›Paper›PMID 29931616›Full record

ArticleJournal of neuro-oncology2018

Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas.

Anupam Kumar, Subhashree Nayak, Pankaj Pathak, Suvendu Purkait, Prit Benny Malgulawar, Mehar Chand Sharma, Vaishali Suri, Arijit Mukhopadhyay, Ashish Suri, Chitra Sarkar

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Blood Pressure and Late Pregnancy Circulating miRNAs in the MADRES Study.Journal of the American Heart Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Anupam KumarDepartment of Neurosurgery, Neurosciences Centre, All India Institute of Medical Sciences - AIIMS, New Delhi, India.
Subhashree NayakDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Pankaj PathakDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Suvendu PurkaitDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Prit Benny MalgulawarDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Mehar Chand SharmaDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Vaishali SuriDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Arijit MukhopadhyayGenomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, Room No. 331, Mathura Road (near Sukhdev Vihar), New Delhi, 110020, India. a.mukhopadhyay@salford.ac.uk.
Ashish SuriDepartment of Neurosurgery, Neurosciences Centre, All India Institute of Medical Sciences - AIIMS, New Delhi, India. surineuro@gmail.com.
Chitra SarkarDepartment of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. sarkar.chitra@gmail.com.ORCID http://orcid.org/0000-0002-4315-9316
All India Institute of Medical Sciences · INInstitute of Genomics and Integrative Biology · IN

Funding

Department of Science and Technology, Ministry of Science and Technology J C Bose fellowship awardIndian Council of Medical Research Research 45/3/13-Geno/BMS
6 · The paper itself

Abstract

introductionAlthough role of individual microRNAs (miRNAs) in the pathogenesis of gliomas has been well studied, their role as a clustered remains unexplored in gliomas.

methodsIn this study, we performed the expression analysis of miR-379/miR-656 miRNA-cluster (C14MC) in oligodendrogliomas (ODGs) and also investigated the mechanism underlying modulation of this cluster.

resultsWe identified significant downregulation of majority of the miRNAs from this cluster in ODGs. Further data from The Cancer Genome Atlas (TCGA) also confirmed the global downregulation of C14MC. Furthermore, we observed that its regulation is maintained by transcription factor MEF2. In addition, epigenetic machinery involving DNA and histone-methylation are also involved in its regulation, which is acting independently or in synergy. The post- transcriptionally regulatory network of this cluster showed enrichment of key cancer-related biological processes such as cell adhesion and migration. Also, there was enrichment of several cancer related pathways viz PIK3 signaling pathway and glioma pathways. Survival analysis demonstrated association of C14MC (miR-487b and miR-409-3p) with poor progression free survival in ODGs.

conclusionOur work demonstrates tumor-suppressive role of C14MC and its role in pathogenesis of ODGs and therefore could be relevant for the development of new therapeutic strategies.

Indexed as

AdultAgedBrainBrain NeoplasmsCell Line, TumorComputational BiologyDNA MethylationDown-RegulationEpigenesis, GeneticFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMaleMicroRNAsMicroRNAsMIRN379 microRNA, humanMIRN656 microRNA, humanRNA, MessengerC14MCMEF2MEG3miRNA clusterOligodendrogliomas

Identifiers

PMID29931616
PMCPMC6061222
OpenAlexW2809009940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.